You are here

Article info

Article menu
Download PDFPDF
Clinical science
Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy?

Authors

  • Patrick J T Chiam Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, Mersey, UK PubMed articlesGoogle scholar articles
  • Sarah E Coupland Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, Mersey, UK PubMed articlesGoogle scholar articles
  • Helen Kalirai Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, Mersey, UK PubMed articlesGoogle scholar articles
  • Carl Groenewald Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, Mersey, UK PubMed articlesGoogle scholar articles
  • Heinrich Heimann Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, Mersey, UK PubMed articlesGoogle scholar articles
  • Bertil E Damato Liverpool Ocular Oncology Centre, Royal Liverpool University Hospital, Liverpool, Mersey, UK Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, Mersey, UK Ocular Oncology Service, Departments of Ophthalmology and Radiation Oncology, University of California San Francisco, San Francisco, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Bertil Damato, Ocular Oncology Service, Department of Ophthalmology and Radiation Oncology, University of California, San Francisco, 10 Koret Way, K304, San Francisco, CA 94143-0730, USA; DamatoB{at}Vision.UCSF.edu
View Full Text

Citation

Chiam PJT, Coupland SE, Kalirai H, et al
Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy?
British Journal of Ophthalmology 2014;98:967-971.

Publication history

  • Received October 13, 2013
  • Revised January 16, 2014
  • Accepted January 20, 2014
  • First published February 11, 2014.
Online issue publication 
June 12, 2014

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions